Published in AIDS Weekly, August 19th, 1996
It says so right there in the patient-information section of the package inserts for the three U.S.- approved protease inhibitors: saquinavir (Hoffman-LaRoche's Invirase), indinavir (Merck's Crixivan), and ritonavir (Abbott's Norvir).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.